Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8652 |
High Similarity |
NPD3027 |
Phase 3 |
0.8472 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8472 |
Intermediate Similarity |
NPD1613 |
Approved |
0.8194 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8194 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8125 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8082 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8075 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8061 |
Intermediate Similarity |
NPD7228 |
Approved |
0.795 |
Intermediate Similarity |
NPD4965 |
Approved |
0.795 |
Intermediate Similarity |
NPD4966 |
Approved |
0.795 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7866 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7831 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7764 |
Intermediate Similarity |
NPD37 |
Approved |
0.773 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7708 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7706 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7665 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7654 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7635 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7564 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7544 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7544 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7516 |
Intermediate Similarity |
NPD1653 |
Approved |
0.75 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7483 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7483 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7455 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7447 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7436 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7431 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7429 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7429 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7415 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7414 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.741 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.74 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7394 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7394 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7376 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7362 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7349 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7337 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7305 |
Intermediate Similarity |
NPD228 |
Approved |
0.7303 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7299 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7262 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7233 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7228 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7207 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7202 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7197 |
Intermediate Similarity |
NPD5588 |
Approved |
0.7188 |
Intermediate Similarity |
NPD7466 |
Approved |
0.7168 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7163 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7163 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7161 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.716 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4538 |
Approved |
0.7134 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7119 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7119 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7105 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD6584 |
Phase 3 |
0.7099 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7095 |
Intermediate Similarity |
NPD5846 |
Approved |
0.7095 |
Intermediate Similarity |
NPD6516 |
Phase 2 |
0.7093 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7086 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7083 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7073 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7063 |
Intermediate Similarity |
NPD7037 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7062 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7059 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7056 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7048 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7032 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7029 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7029 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7025 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.702 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7019 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7019 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7011 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7011 |
Intermediate Similarity |
NPD27 |
Approved |
0.7006 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7006 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7 |
Intermediate Similarity |
NPD1091 |
Approved |
0.6994 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6994 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.6994 |
Remote Similarity |
NPD3051 |
Approved |
0.6989 |
Remote Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6983 |
Remote Similarity |
NPD7310 |
Approved |
0.6983 |
Remote Similarity |
NPD7312 |
Approved |
0.6983 |
Remote Similarity |
NPD8312 |
Approved |
0.6983 |
Remote Similarity |
NPD8313 |
Approved |
0.6983 |
Remote Similarity |
NPD4577 |
Approved |
0.6983 |
Remote Similarity |
NPD4578 |
Approved |
0.6983 |
Remote Similarity |
NPD7313 |
Approved |
0.6983 |
Remote Similarity |
NPD7311 |
Approved |
0.6982 |
Remote Similarity |
NPD6818 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6978 |
Remote Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD3892 |
Phase 2 |
0.6975 |
Remote Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD4110 |
Phase 3 |
0.6962 |
Remote Similarity |
NPD6353 |
Approved |
0.6962 |
Remote Similarity |
NPD6653 |
Approved |
0.6959 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6954 |
Remote Similarity |
NPD2970 |
Approved |
0.6954 |
Remote Similarity |
NPD2969 |
Approved |
0.6944 |
Remote Similarity |
NPD7309 |
Approved |
0.6943 |
Remote Similarity |
NPD5837 |
Clinical (unspecified phase) |
0.6943 |
Remote Similarity |
NPD4140 |
Approved |
0.6937 |
Remote Similarity |
NPD2161 |
Phase 2 |
0.6937 |
Remote Similarity |
NPD6099 |
Approved |
0.6937 |
Remote Similarity |
NPD6100 |
Approved |
0.6928 |
Remote Similarity |
NPD3094 |
Phase 2 |
0.6923 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6914 |
Remote Similarity |
NPD5177 |
Phase 3 |
0.6914 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6914 |
Remote Similarity |
NPD3060 |
Approved |
0.6914 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD6582 |
Phase 2 |
0.6908 |
Remote Similarity |
NPD6583 |
Phase 3 |
0.6897 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6894 |
Remote Similarity |
NPD3540 |
Phase 1 |
0.6894 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6894 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD7819 |
Suspended |
0.6882 |
Remote Similarity |
NPD2977 |
Approved |
0.6882 |
Remote Similarity |
NPD5773 |
Approved |
0.6882 |
Remote Similarity |
NPD5772 |
Approved |
0.6882 |
Remote Similarity |
NPD2978 |
Approved |
0.6875 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6871 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6871 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6871 |
Remote Similarity |
NPD6671 |
Approved |
0.6867 |
Remote Similarity |
NPD7526 |
Approved |
0.6867 |
Remote Similarity |
NPD52 |
Approved |
0.6867 |
Remote Similarity |
NPD7527 |
Clinical (unspecified phase) |
0.6848 |
Remote Similarity |
NPD4357 |
Discontinued |
0.6845 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6842 |
Remote Similarity |
NPD2560 |
Approved |
0.6842 |
Remote Similarity |
NPD2563 |
Approved |
0.6842 |
Remote Similarity |
NPD5402 |
Approved |
0.6835 |
Remote Similarity |
NPD2238 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD3539 |
Phase 1 |
0.6829
|
Remote Similarity |
NPD2677 |
Approved |